Therapeutic Focus Areas

Overview:

- We currently have 22 disease-focused programmes, each protected by patents, archived in an international repository, and supported by successful pilot studies and toxicology evaluations.

- Several of these programmes have advanced further, having initiated or completed their preclinical trial phases.

​​

Legal Structure:

- Each disease-area project is incorporated as a separate subsidiary under Cell & Gene Therapy Ltd., ensuring independent intellectual property rights.

- This approach allows investors to support a specific disease-area project rather than the entire parent company.

​​

Partnerships & Alliances:

- If you would like to learn more or explore collaboration opportunities, please contact us.